MONTREAL, CANADA--(Marketwire - November 28, 2007) - ART Advanced Research Technologies Inc. (“ART”)(TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Mr. Rik van Heijningen has joined the Company as Director of European Commercial Operations, Preclinical Imaging. With over 15 years of top-level sales, marketing, and management experience behind him, Mr. van Heijningen will lead the implementation of a commercial team to support the current and future Optix® customer base in Europe. His primary responsibility is to implement a results-oriented sales, service, and technical support team to grow market share for ART’s preclinical imaging products. Prior to joining ART, Mr. van Heijningen was Vice President Commercial Operations at Kreatech Biotechnology BV, and held various leadership positions at Invitrogen BV and Dynal Biotech ASA, where he distinguished himself as a customer-focused manager.
